These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8103818)

  • 41. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.
    Russo C; Angelini G; Dapino D; Piccini A; Piombo G; Schettini G; Chen S; Teller JK; Zaccheo D; Gambetti P; Tabaton M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15598-602. PubMed ID: 9861015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The neurobiology and pharmacotherapy of Alzheimer's disease.
    Felician O; Sandson TA
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):19-31. PubMed ID: 9990552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Alzheimer's disease and the association of genetic polymorphism of apolipoprotein E and liquor beta protein in Finns].
    Lehtimäki T; Pirttilä T; Frey H; Nikkari T
    Duodecim; 1995; 111(5):401-7. PubMed ID: 8674441
    [No Abstract]   [Full Text] [Related]  

  • 44. [Memory mechanisms and expectancy of therapy in Alzheimer's disease].
    Vetulani J
    Neurol Neurochir Pol; 2000; 34(3):429-46. PubMed ID: 10979538
    [No Abstract]   [Full Text] [Related]  

  • 45. Protective effect of apoE epsilon 2 in Alzheimer's disease.
    Benjamin R; Leake A; McArthur FK; Ince PG; Candy JM; Edwardson JA; Morris CM; Bjertness E
    Lancet; 1994 Aug; 344(8920):473. PubMed ID: 7914580
    [No Abstract]   [Full Text] [Related]  

  • 46. Alzheimer's disease. Risky apolipoprotein in brain.
    Goedert M; Strittmatter WJ; Roses AD
    Nature; 1994 Nov; 372(6501):45-6. PubMed ID: 7969418
    [No Abstract]   [Full Text] [Related]  

  • 47. [Molecular mechanism underlying the development of Alzheimer's disease: implications of apolipoprotein E and presenilin].
    Yanagisawa K
    Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):455-7. PubMed ID: 11523146
    [No Abstract]   [Full Text] [Related]  

  • 48. MR spectroscopy, APOE genotype, and evolving β-amyloid pathology: What is being detected and when.
    Kantarci K; Goldberg TE
    Neurology; 2016 May; 86(19):1750-1. PubMed ID: 27164709
    [No Abstract]   [Full Text] [Related]  

  • 49. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease.
    Hardy J
    Am J Med Genet; 1995 Oct; 60(5):456-60. PubMed ID: 8546162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein E and Alzheimer's disease.
    Strittmatter WJ
    Ann N Y Acad Sci; 2000; 924():91-2. PubMed ID: 11193808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer's disease and apolipoprotein E epsilon 4 allele in older drivers who died in automobile accidents.
    Johansson K; Bogdanovic N; Kalimo H; Winblad B; Viitanen M
    Lancet; 1997 Apr; 349(9059):1143-4. PubMed ID: 9113015
    [No Abstract]   [Full Text] [Related]  

  • 52. [Calcium hypothesis of Alzheimer disease].
    Riazantseva MA; Mozhaeva GN; Kaznacheeva EV
    Usp Fiziol Nauk; 2012; 43(4):59-72. PubMed ID: 23227722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alzheimer's disease and the apolipoprotein E epsilon 4 allele.
    Friedman G; Ben Yehuda A
    Isr J Med Sci; 1994 Jul; 30(7):545-7. PubMed ID: 8050887
    [No Abstract]   [Full Text] [Related]  

  • 54. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
    Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
    N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations].
    Okochi M; Takeda M
    Nihon Rinsho; 2004 Jan; 62 Suppl():86-9. PubMed ID: 15011326
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
    Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
    PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Handb Clin Neurol; 2008; 89():245-60. PubMed ID: 18631749
    [No Abstract]   [Full Text] [Related]  

  • 58. Is Alzheimer's disease an apolipoprotein E amyloidosis?
    Wisniewski T; Lalowski M; Golabek A; Vogel T; Frangione B
    Lancet; 1995 Apr; 345(8955):956-8. PubMed ID: 7715296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alzheimer's disease: genetic variables and risk.
    Secko D
    CMAJ; 2005 Mar; 172(5):627. PubMed ID: 15738483
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical correlates of apolipoprotein E in Alzheimer's disease.
    Frisoni GB; Bianchetti A; Govoni S; Trabucchi M
    Ann Neurol; 1996 Oct; 40(4):688-9. PubMed ID: 8871593
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.